|
1. BIOLOGIE
|
|
|
Neurons promote growth of brain tumor cells [DKFZ]
|
|
|
|
|
|
“The tumor cells are not only interconnected in the brain like neurons; they also receive direct signals from them,” explained Winkler, whose research group is affiliated with the University Hospital and the DKFZ.
|
|
|
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
|
|
|
|
Real-Time Digital Surveillance of Vaping-Induced Pulmonary Disease [NEJM]
|
|
|
|
|
|
This report provides an integrated view of the vaping-related pulmonary disease outbreak since late July 2019. We collected online information from disparate sources including news aggregators, eyewitness reports, and validated official alerts and curated and classified the data by disease case, location, and time.
|
|
|
|
|
|
|
4.9 DÉP., DIAG. & PRONO. - SEIN
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)
|
|
|
|
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2019 [EMA]
|
|
|
|
|
|
- The Committee recommended granting a marketing authorisation for Xospata* (gilteritinib) for the treatment of adult patients who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation. - The CHMP recommended granting marketing authorisations for three generic medicines: Arsenic trioxide Accord (arsenic trioxide), for the treatment of acute promyelocytic leukaemia; Bortezomib Fresenius Kabi (bortezomib), for the treatment of multiple myeloma and mantle cell lymphoma; and Ivozall (clofarabine), for the treatment of acute lymphoblastic leukaemia in paediatric patients.
|
|
|
|
|
|
|
|
5.6 ESMO
|
|
|
|
|
6.10 POLITIQUES
|
|
|
|
6.10.1 POLITIQUES (USA)
|
|
|
NIH set for $3B funding boost under Senate budget proposal [Fierce Biotech]
|
|
|
|
|
|
Despite President Donald Trump repeatedly threatening to cut the NIH’s budget, the agency has received more money in recent years as a result of support in Congress. That pattern looks set to continue in fiscal 2020, with the Senate Committee on Appropriations proposing another increase to the NIH’s budget.
|
|
|
|
|
|